News

InvestmentPitch Media Video Discusses Reliq Health’s Signing of Significant New Contract with a Leading US healthcare Company with 75 Locations in 8 States

VANCOUVER, British Columbia, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global…

1 year ago

Immuron achieves record monthly Travelan® sales

Highlights: Record monthly Travelan® salesAustralian sales of A$1.18 M in August 2023 (7984% increase on August 2022 sales)MELBOURNE, Australia, Sept.…

1 year ago

Bavarian Nordic Awarded Another Contract to Supply Smallpox Vaccines for EU Strategic Reserve

COPENHAGEN, Denmark, September 13, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today, that it has been awarded another contract…

1 year ago

Philips extends its mobile C-arm range with Zenition 30, alleviating staff shortages by empowering surgeons with greater personalization and control

Philips Zenition 30 in use Philips Zenition 30 product photo September 13, 2023 Offering surgeons greater flexibility, control, and personalization…

1 year ago

Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Development

LONDON, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Myricx Bio (‘Myricx’), a UK biotech company focusing on the discovery and development…

1 year ago

Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval

UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support…

1 year ago

Neuroscience Center in Sweden Orders Nexstim NBS 5 System

Press release, Helsinki, 13 September 2023 at 10 AM (EEST) Neuroscience Center in Sweden Orders Nexstim NBS 5 System Nexstim…

1 year ago

Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update

The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022.Updated clinical and preclinical data on…

1 year ago

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease

Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration VenturesSeptember 13, 2023: Glasgow, Scotland – Mironid,…

1 year ago